Activity of enisamium, an isonicotinic acid derivative, against influenza viruses in differentiated normal human bronchial epithelial cells

AIMS: New therapeutics for the control of influenza virus infections are needed to alleviate the burden caused by seasonal epidemics and occasional pandemics, and to overcome the potential risk of drug-resistance emergence. Enisamium iodide (Amizon®, Farmak) is currently approved for clinical use fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Boltz, David, Peng, Xinjian, Muzzio, Miguel, Dash, Pradyot, Thomas, Paul G, Margitich, Victor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961345/
https://www.ncbi.nlm.nih.gov/pubmed/30466301
http://dx.doi.org/10.1177/2040206618811416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961345/
https://www.ncbi.nlm.nih.gov/pubmed/30466301
http://dx.doi.org/10.1177/2040206618811416

Ejemplares similares